| Followed By | 757 |
| Posts | 50965 |
| Boards Moderated | 15 |
| Alias Born | 12/12/2004 |
- MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH • GlobeNewswire Inc. • 07/26/2022 12:00:00 PM
- H.C. Wainwright Thinks MoonLake Immunotherapeutics’ Stock is Going to Recover • TipRanks • 07/21/2022 10:26:07 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 06/07/2022 12:33:47 PM
- Amended Current Report Filing (8-k/a) • Edgar (US Regulatory) • 05/16/2022 08:19:04 PM
- MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa • GlobeNewswire Inc. • 05/12/2022 11:00:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/05/2022 10:05:05 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/05/2022 09:53:41 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/05/2022 09:53:35 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/05/2022 09:51:01 PM
- Statement of Beneficial Ownership (sc 13d) • Edgar (US Regulatory) • 04/18/2022 08:49:52 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:08:34 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:08:13 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:08:06 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:08:05 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:07:52 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:07:44 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:07:42 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:07:41 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 04/15/2022 08:07:33 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 04/11/2022 08:41:50 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/07/2022 10:29:14 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/07/2022 10:28:03 PM
OTC: ILUS, ILUS International (Ilustrato Pictures International Inc.) Confirms the Settlement of Two $500,000 Notes and Announces a Further $5.6 Million in Funding • ILUS • Aug 8, 2022 1:49 PM
Progressive Care Announces Launch of New Logo as It Continues to Upgrade and Strengthen Its PharmcoRx Brand • RXMD • Aug 8, 2022 10:42 AM
Current Developments at Argentum 47, Inc. and Roadmap to 2023 • ARGQD • Aug 8, 2022 10:29 AM
Kona Gold Beverage, Inc Expands Sales Team • KGKG • Aug 8, 2022 9:00 AM
The Power of Science to Stop a Killer • NVS • Aug 8, 2022 8:45 AM
Mru Patel Appointed Non-Executive Director of Axis Technologies Group, Inc. • AXTG • Aug 5, 2022 9:00 AM
HealthLynked to Premier "Forever: The End of Aging" Medical Documentary atCMX CinéBistro Theater in Naples, Florida on August 28th • HLYK • Aug 5, 2022 8:00 AM
Progressive Care Announces Shareholder Conference Call and Business Update on August 11, 2022 • RXMD • Aug 5, 2022 7:15 AM
IGEN announces Net Profit for Second Quarter 2022 • IGEN • Aug 5, 2022 7:08 AM
Kaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon • KAYS • Aug 4, 2022 12:44 PM
American Rebel Holdings Completes Acquisition of Champion Safe Company, Solidifying A Leading Position in Safe Industry • AREBW • Aug 4, 2022 10:27 AM
OTC: ILUS, ILUS International (Ilustrato Pictures International Inc), Summarizes Its Second Quarter of 2022 Results, Including a 588% Revenue Increase Over the Same Period in 2021 • ILUS • Aug 4, 2022 10:19 AM
New Intranet- and Cloud-based Monitoring and Management Interface Enhances ResGreen's BotWay Software • RGGI • Aug 3, 2022 10:53 AM
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics • TOMDF • Aug 3, 2022 9:48 AM
EV TECHNOLOGY GROUP ANNOUNCES AGREEMENT TO ACQUIRE UP TO 100% OF FABLINK GROUP, SPEARHEADING FUTURE GLOBAL GROWTH • EVTG • Aug 3, 2022 9:39 AM
| Volume: | |
| Day Range: | |
| Bid: | |
| Ask: | |
| Last Trade Time: | |
| Total Trades: |
- 1D
- 1M
- 2M
- 3M
- 6M
- 1Y
- 2Y
- 3Y
- 5Y
Follow Board